IL134185A - Preparation of nevirapine hemihydrate and pharmaceutical suspensions containing it - Google Patents

Preparation of nevirapine hemihydrate and pharmaceutical suspensions containing it

Info

Publication number
IL134185A
IL134185A IL13418598A IL13418598A IL134185A IL 134185 A IL134185 A IL 134185A IL 13418598 A IL13418598 A IL 13418598A IL 13418598 A IL13418598 A IL 13418598A IL 134185 A IL134185 A IL 134185A
Authority
IL
Israel
Prior art keywords
preparation
suspensions containing
pharmaceutical suspensions
nevirapine hemihydrate
nevirapine
Prior art date
Application number
IL13418598A
Other languages
English (en)
Other versions
IL134185A0 (en
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL134185(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL134185A0 publication Critical patent/IL134185A0/xx
Publication of IL134185A publication Critical patent/IL134185A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13418598A 1997-08-25 1998-08-11 Preparation of nevirapine hemihydrate and pharmaceutical suspensions containing it IL134185A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25
PCT/US1998/016581 WO1999009990A1 (en) 1997-08-25 1998-08-11 Pharmaceutical suspension comprising nevirapine hemihydrate

Publications (2)

Publication Number Publication Date
IL134185A0 IL134185A0 (en) 2001-04-30
IL134185A true IL134185A (en) 2005-11-20

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13418598A IL134185A (en) 1997-08-25 1998-08-11 Preparation of nevirapine hemihydrate and pharmaceutical suspensions containing it

Country Status (37)

Country Link
US (2) US6172059B1 (cs)
EP (1) EP1019058B1 (cs)
JP (1) JP3472261B2 (cs)
KR (1) KR100426516B1 (cs)
CN (1) CN1197578C (cs)
AR (2) AR016869A1 (cs)
AT (1) ATE326971T1 (cs)
AU (1) AU742761B2 (cs)
BG (1) BG64337B1 (cs)
BR (1) BR9811994B1 (cs)
CA (1) CA2301646C (cs)
CL (1) CL2008003111A1 (cs)
CO (1) CO4970742A1 (cs)
CY (1) CY1105228T1 (cs)
CZ (1) CZ290667B6 (cs)
DE (1) DE69834655T2 (cs)
DK (1) DK1019058T3 (cs)
EG (1) EG24075A (cs)
ES (1) ES2265666T3 (cs)
HR (1) HRP980461B1 (cs)
HU (1) HU226063B1 (cs)
ID (1) ID21650A (cs)
IL (1) IL134185A (cs)
MY (1) MY122272A (cs)
NO (1) NO326226B1 (cs)
NZ (1) NZ503414A (cs)
PE (1) PE105799A1 (cs)
PL (1) PL192361B1 (cs)
PT (1) PT1019058E (cs)
RS (1) RS49808B (cs)
RU (1) RU2196584C2 (cs)
SA (1) SA98190680B1 (cs)
TR (1) TR200000490T2 (cs)
TW (1) TW450812B (cs)
UA (1) UA44370C2 (cs)
WO (1) WO1999009990A1 (cs)
ZA (1) ZA987623B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
WO2003091290A1 (en) * 2002-04-23 2003-11-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for reduction of residual organic solvent in carbomer
BRPI0617074A2 (pt) * 2005-08-31 2011-07-12 Cipla Ltd composição farmacêutica, uso de lamivudina, nevirapina e stavudina, uso de stavudina, lamivudina e nevirapina, método para tratar uma infecção viral em um humano, método para preparar uma composição farmacêutica, método para preparar uma forma de dosagem unitária farmacêutica bicamadas e método para preparar uma forma de dosagem unitária farmacêutica tri-camadas
EP2306980A2 (en) * 2008-06-30 2011-04-13 Tibotec Pharmaceuticals Powders for reconstitution
BR112012011095A2 (pt) * 2009-11-10 2015-10-06 Univ Northwest método para aumentar a solubilidade de uma composição inibidora de transcriptase
DE112010004862T5 (de) * 2009-12-17 2012-12-06 North West University Polymorphe Form von Nevirapin und deren Herstellung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2019812C (en) * 1989-06-28 2000-11-21 Gunther Schmidt (Deceased) Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
GB9215178D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
HUT74681A (en) * 1993-12-15 1997-01-28 Merck & Co Inc N-(2-hydroxy-1-indenyl)-2-phenylmethyl-4-hydroxy-5-(2-carboxamido-piperazinyl)-pentaneamide derivatives of hiv protease inhibitor activity and phrmaceutical compositions contining them
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
CN1197578C (zh) 2005-04-20
EP1019058A1 (en) 2000-07-19
JP2001513564A (ja) 2001-09-04
EP1019058A4 (en) 2004-11-10
YU9800A (sh) 2001-12-26
ZA987623B (en) 2000-03-22
AR083451A2 (es) 2013-02-27
AU742761B2 (en) 2002-01-10
TR200000490T2 (tr) 2000-08-21
TW450812B (en) 2001-08-21
CZ2000694A3 (cs) 2000-09-13
PE105799A1 (es) 1999-11-16
BG104133A (bg) 2000-08-31
EP1019058B1 (en) 2006-05-24
CZ290667B6 (cs) 2002-09-11
ATE326971T1 (de) 2006-06-15
RU2196584C2 (ru) 2003-01-20
CY1105228T1 (el) 2010-03-03
CA2301646A1 (en) 1999-03-04
DK1019058T3 (da) 2006-06-12
ES2265666T3 (es) 2007-02-16
HRP980461A2 (en) 1999-06-30
HU226063B1 (hu) 2008-04-28
CN1268055A (zh) 2000-09-27
RS49808B (sr) 2008-08-07
EG24075A (en) 2008-05-11
UA44370C2 (uk) 2002-02-15
NO20000906L (no) 2000-02-24
AR016869A1 (es) 2001-08-01
CA2301646C (en) 2008-11-18
NO326226B1 (no) 2008-10-20
BG64337B1 (bg) 2004-10-29
SA98190680B1 (ar) 2006-04-04
AU8777198A (en) 1999-03-16
KR100426516B1 (ko) 2004-04-13
PL338828A1 (en) 2000-11-20
HRP980461B1 (en) 2002-08-31
DE69834655T2 (de) 2006-12-14
US6255481B1 (en) 2001-07-03
IL134185A0 (en) 2001-04-30
BR9811994B1 (pt) 2013-11-19
DE69834655D1 (de) 2006-06-29
BR9811994A (pt) 2000-09-05
PL192361B1 (pl) 2006-10-31
KR20010023257A (ko) 2001-03-26
HK1027975A1 (en) 2001-02-02
CL2008003111A1 (es) 2009-09-11
US6172059B1 (en) 2001-01-09
ID21650A (id) 1999-07-08
CO4970742A1 (es) 2000-11-07
HUP0003093A2 (hu) 2001-08-28
JP3472261B2 (ja) 2003-12-02
NZ503414A (en) 2002-11-26
NO20000906D0 (no) 2000-02-24
MY122272A (en) 2006-04-29
WO1999009990A1 (en) 1999-03-04
PT1019058E (pt) 2006-08-31

Similar Documents

Publication Publication Date Title
HUP0004556A3 (en) Tetrazole-containing rapamycin analogs and their use for preparation of pharmaceutical compositions
IS5409A (is) Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
EG24044A (en) pharmaceutical formulation of omeprazole
HUP0101999A3 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
ZA967654B (en) Electrodes and methods of preparation thereof
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
IL119316A0 (en) Hydroxypyridinones their preparation and pharmaceutical compositions containing them
ZA986437B (en) Derivatives of acyl-piperazinyl-pyrimidines their preparation and application as medicaments
EP1033994A4 (en) METHOD FOR PRODUCING BIOGINKGO
ZA984266B (en) Pharmaceutical composition and process of preparation
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
ZA988496B (en) Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
IL132516A0 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
IL118054A0 (en) (Het) aryloxy-,(-thio- and -amino-)-crotonates their preparation and pharmaceutical compositions containing them
IL134185A (en) Preparation of nevirapine hemihydrate and pharmaceutical suspensions containing it
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
ZA986047B (en) 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application
PL341599A1 (en) Novel derivatives of p-aminophenol and their application
IL122651A (en) Zwitterionic polymorphic forms of trovafloxacin their preparation and pharmaceutical compositions containing them
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
NZ307236A (en) Preparation of streptogramins
HU9800536D0 (en) Novel secomacrolides from class of erythromycins and process for their preparation
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees